Incidence of serious adverse events caused by tyrosine kinase inhibitor treatment following immune checkpoint inhibitor therapy in advanced NSCLC patients with oncogenic driver alterations

被引：0
|
作者：
Yukiko Shimoda
Tatsuya Yoshida
Jun Miyakoshi
Masahiro Torasawa
Akiko Tateishi
Yuji Matsumoto
Ken Masuda
Yuki Shinno
Yusuke Okuma
Yasushi Goto
Hidehito Horinouchi
Noboru Yamamoto
Yuichiro Ohe
机构：
[1] National Cancer Center Hospital,Department of Thoracic Oncology
[2] National Cancer Center Hospital,Department of Experimental Therapeutics
来源：
Cancer Immunology, Immunotherapy | 2023年 / 72卷
关键词：
Non-small cell lung cancer; Sequential therapy; Dosing interval; Serious adverse events;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2613 / 2621
页数：8
相关论文
共 50 条
  • [41] Clinical guideline highlights for the hospitalist: Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy
    Chitnis, Saurabh D.
    Mortazavi, Amir
    JOURNAL OF HOSPITAL MEDICINE, 2023, 18 (11) : 1013 - 1016
  • [42] A digital therapeutic for proactive monitoring of patients on immune checkpoint inhibitor therapy for early detection of immune-related adverse events
    Singhal, Shyamali Mallick
    Dormady, Shane
    Li, Jiali
    Singhal, Shiva
    Chin, Lynda
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [43] Immune-related adverse events in patients with pre-existing autoimmune rheumatologic disease on immune checkpoint inhibitor therapy
    Amanda Lusa
    Carolina Alvarez
    Shruti Saxena Beem
    Todd A. Schwartz
    Rumey Ishizawar
    BMC Rheumatology, 6
  • [44] Treatment-Related Adverse Events of Combination EGFR Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
    Chan, Daisy Wai-Ka
    Choi, Horace Cheuk-Wai
    Lee, Victor Ho-Fun
    CANCERS, 2022, 14 (09)
  • [45] Exploring the clinical significance of specific immune-related adverse events in melanoma patients undergoing immune checkpoint inhibitor therapy
    Asher, Nethanel
    Bar-Hai, Neta
    Ben-Betzalel, Guy
    Stoff, Ronen
    Grynberg, Shirly
    Schachter, Jacob
    Frommer-Shapira, Ronnie
    MELANOMA RESEARCH, 2024, 34 (05) : 439 - 449
  • [46] Incidence and Timing of Immune-Related Adverse Events in Immune-Checkpoint Inhibitor-Treated Patients: A Retrospective Observational Study
    Masaki, Kou
    Miyazaki, Motoyasu
    Kakimoto, Hideki
    Fukiage, Yuma
    Fukue, Haruka
    Nakashima, Akio
    Imakyure, Osamu
    Sparreboom, Alex
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (24)
  • [47] Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors
    Yoshikawa, Yuki
    Imamura, Michio
    Yamauchi, Masami
    Hayes, C. Nelson
    Aikata, Hiroshi
    Okamoto, Wataru
    Miyata, Yoshihiro
    Okada, Morihito
    Hattori, Noboru
    Sugiyama, Kazuhiko
    Yoshioka, Yukio
    Toratani, Shigeaki
    Takechi, Masaaki
    Ichinohe, Tatsuo
    Ueda, Tsutomu
    Takeno, Sachio
    Kobayashi, Tsuyoshi
    Ohdan, Hideki
    Teishima, Jun
    Hide, Michihiro
    Nagata, Yasushi
    Kudo, Yoshiki
    Iida, Koji
    Chayama, Kazuaki
    BMC CANCER, 2022, 22 (01)
  • [48] Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors
    Yuki Yoshikawa
    Michio Imamura
    Masami Yamauchi
    C. Nelson Hayes
    Hiroshi Aikata
    Wataru Okamoto
    Yoshihiro Miyata
    Morihito Okada
    Noboru Hattori
    Kazuhiko Sugiyama
    Yukio Yoshioka
    Shigeaki Toratani
    Masaaki Takechi
    Tatsuo Ichinohe
    Tsutomu Ueda
    Sachio Takeno
    Tsuyoshi Kobayashi
    Hideki Ohdan
    Jun Teishima
    Michihiro Hide
    Yasushi Nagata
    Yoshiki Kudo
    Koji Iida
    Kazuaki Chayama
    BMC Cancer, 22
  • [49] y Diagnosis and treatment of immune-related adverse events during checkpoint inhibitor therapy in intensive care medicine
    d'Hargues, Y.
    Prinz, J.
    Goedel, P.
    Shimabukuro-Vornhagen, A.
    Kochanek, M.
    Boell, B.
    MEDIZINISCHE KLINIK-INTENSIVMEDIZIN UND NOTFALLMEDIZIN, 2020, 115 (04) : 281 - 285
  • [50] Do we need skin toxicity? Association of immune checkpoint inhibitor and tyrosine kinase inhibitor-related cutaneous adverse events with outcomes in metastatic renal cell carcinoma
    Corona-Rodarte, Eduardo
    Olivas-Martinez, Antonio
    Remolina-Bonilla, Yuly A.
    Dominguez-Cherit, Judith G.
    Lam, Elaine T.
    Bourlon, Maria T.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (10) : 1242 - 1247
12345